Landec Corporation

Other

Adam Warwick Bell

Stelios Tzannis

Steven P Bitler

David D Taft

Qiang Zheng

Wei-Guo Dai

Sandra Ottensmann

Natarajan Balachander

Mandy Jane Ward

Peter James Stragnola

Sandra N Ottensmann

Stelios T Tzannis

The invention provides fabrics that incorporate enzymes that inactivate microbial pathogens, particularly enveloped viral particles such as those of Influenza virus and Coronavirus such as Covid-19. The fabrics of the invention may be used in the production of various items including protective facemasks.

Enzyme-enhanced anti-viral fabrics

Formulations of drugs and crystalline side chain polymers to provide controlled and/or sustained release drug formulations.

Delivery of drugs

PLGA, PLA and PGA polymers which have crystallinity resulting from the presence of long chain alkyl groups in terminal units. The polymers are particularly useful for drug delivery.

Polymer formulations for delivery of bioactive materials

Systems and methods for delivering release materials, for example drugs and other bioactive materials. Crystalline polymeric systems, referred to as CYC carriers, are associated with the release materials, through chemical bonding or through physical association. The crystallinity of the CYC carriers results from the presence of crystallizable side chains, for example long chain n-alkyl moieties, which results in relatively low and sharp melting temperatures. One class of CYC carriers, referred to as CYSC polymers, have a majority of the crystallizable side chains pendant from the polymer backbone. Another class of CYC carriers referred to as ECC polymers, have a majority of the crystallizable side chains attached to terminal units of the polymer backbone. The ECC polymers can for example be obtained by modification of PLGA polymers. The CYC carriers in another class of non-polymeric. Some CYC carriers, referred to as CYC assemblies, have enhanced crystallinity as a result of the physical association of crystallizable moieties which are present in different types of molecule, for example between a polymer containing crystallizable moieties and a monomer containing crystallizable moieties. For some uses, particularly the delivery of drugs, a bioerodable CYC carrier is preferably used.

Systems and methods for delivery of materials

Methods for making formulations of drugs and crystalline side chain polymers which formulations provide controlled and/or sustained release drug formulations.

Method for formulating a controlled-release pharmaceutical formulation

Delivery of drugs in association with PLGA polymers which have crystallinity resulting from the presence of long chain alkyl groups in terminal units.

Methods and devices for cheaply, simply and efficiently keeping drains clear of roots involving the delivery of a root retardent hormone into drain pipes by incorporating the hormone into a tablet that is placed into a drainage system such as a toilet tank, thereby delivering the hormone to the drain pipes each time the toilet is flushed.

Growing community of inventors

San Francisco, CA, United States of America

Adam Warwick Bell